PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 112 filers reported holding PULMONX CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,968,196 | -1.8% | 2,029,835 | +24.7% | 0.00% | 0.0% |
| Q2 2023 | $21,343,146 | -0.8% | 1,628,005 | -15.4% | 0.00% | +100.0% |
| Q1 2023 | $21,521,456 | +7137.3% | 1,924,996 | +5357.1% | 0.00% | – |
| Q4 2022 | $297,368 | -57.2% | 35,275 | -15.5% | 0.00% | – |
| Q3 2022 | $695,000 | +14.7% | 41,741 | +1.4% | 0.00% | – |
| Q2 2022 | $606,000 | -41.1% | 41,177 | -0.7% | 0.00% | – |
| Q1 2022 | $1,029,000 | -93.3% | 41,458 | -91.4% | 0.00% | -100.0% |
| Q4 2021 | $15,435,000 | -11.5% | 481,254 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $17,442,000 | +40.4% | 484,785 | +72.2% | 0.00% | 0.0% |
| Q2 2021 | $12,423,000 | -43.4% | 281,568 | -41.3% | 0.00% | -50.0% |
| Q1 2021 | $21,948,000 | -44.7% | 479,860 | -16.5% | 0.00% | -50.0% |
| Q4 2020 | $39,684,000 | – | 574,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |